AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Mantovani, G Maccio, A Lai, P Massa, E Massa, D Mulas, C Succu, G Mudu, MC Manca, G Versace, R Pisano, M
Citation: G. Mantovani et al., Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetateand recombinant interleukin-2 in patients with inoperable primary lung cancer, J IMMUNOTH, 23(2), 2000, pp. 267-274

Authors: Mantovani, G Maccio, A Massa, E Mulas, C Mudu, MC Massidda, S Massa, D Murgia, V Ferreli, L Succu, G Astara, G Proto, E Tore, G Mura, M Maxia, G
Citation: G. Mantovani et al., Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical outcome, toxicity and organ/function preservation, INT J ONCOL, 16(6), 2000, pp. 1227-1233

Authors: Mantovani, G Maccio, A Massa, E Mulas, C Mudu, MC Massidda, S Massa, D Murgia, V Ferreli, L Succu, G Astara, G Proto, E Tore, G Mura, M Maxia, G
Citation: G. Mantovani et al., Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical response and organ/function preservation, ONCOL REP, 6(6), 1999, pp. 1425-1430

Authors: Mantovani, G Ghiani, M Curreli, L Maccio, A Massa, D Succu, G Lai, P Massa, E Mudu, MC Astara, G
Citation: G. Mantovani et al., Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients, ONCOL REP, 6(2), 1999, pp. 421-426

Authors: Mantovani, G Curreli, L Maccio, A Massa, E Massa, D Mulas, C Succu, G Contu, P
Citation: G. Mantovani et al., Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute anddelayed N&V: First clinical report, ANTICANC R, 19(4C), 1999, pp. 3495-3502
Risultati: 1-5 |